Merck KGaA Sees Return to Organic Sales Growth Next Year
October 19 2023 - 2:50AM
Dow Jones News
By Adria Calatayud
Germany's Merck KGaA expects to return to organic sales growth
next year after a broadly flat performance in 2023, helped by
reduced Covid-19 headwinds and recovering demand for semiconductor
materials.
The German life-sciences and electronics group said Thursday
that it still expects organic sales for 2023 to range from a 2%
fall to a 2% rise, resulting in net sales of between 20.5 billion
and 21.9 billion euros ($21.60 billion-$23.08 billion).
In 2024, the decline in Covid-19-related sales in Merck's
life-sciences segment will be smaller than in 2023, it said.
Inventory reductions by key customers of the company's
process-solutions segment should end early next year, paving the
way for a pick-up in sales, Merck said.
The market for semiconductor materials is expected to recover
incrementally in 2024, Merck said. Moreover, the company
anticipates growth in its healthcare segment to normalize in line
with medium-term aspirations.
Merck said its medium-term growth targets to 2025 remain
unchanged, and that it expects to continue to grow beyond 2025.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 19, 2023 02:35 ET (06:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Nov 2024 to Dec 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Dec 2023 to Dec 2024
